The day-long event spread across three sessions is Jointly being organized by the Bombay Hemp Company (BOHECO) and the Council of Scientific and Industrial Research (CSIR) — Indian Institute of Integrative Medicine (IIIM).
Dr. Jitendra Singh, Minister of State for Development of North Eastern Region and Minister of State for Prime Minister’s Office, will be the chief guest.
DELHI / November 20, 2018 – The Council of Scientific and Industrial Research (CSIR) — Indian Institute of Integrative Medicine (IIIM) and the Bombay Hemp Company (BOHECO) are jointly organizing a conference to promote research on cannabis and its medical uses in India, titled “Cannabis R&D in India: A Scientific, Medical & Legal Perspective,’ on November 23 in Delhi.
Note: Cannabis means in Hindi: Bhang or Ganja
The day-long conference will see participation of prominent medical experts, policymakers and researchers, including Dr. Jitendra Singh, Minister of State for Development of North Eastern Region and Minister of State for Prime Minister’s Office; Dr. Ram Vishwakarma, Director – CSIR-IIIM; Dr. Rajendra Badwe, Director, Tata Memorial Hospital, Mumbai; Dr. Dharamvira Gandhi, Member of Parliament (Lok Sabha); Dr. Rajender Pal Singh, Former DDG (North Zone), Narcotics Control Bureau; Dr. Sanjay Kumar, Director, CSIR-Institute of Himalayan Bio-resource Technology; Dr. Manjari Tripathi, Head (Neurology), All India Institute of Medical Sciences; and Dr. Anurag Srivastava, Head (Surgery), All India Institute of Medical Sciences.
The conference will be spread across three-panel discussions including:
(1) Cannabis in Medicine: India’s journey towards reclaiming the medicinal benefits of Cannabis and what lessons can be learned from previous efforts
(2) Domestication, cultivation and scientific interventions in Cannabis: the Indian scenario, and
Said Jahan Peston Jamas, Co-founder, Bombay Hemp Company: “The cannabis plant is a victim of misperception despite being an integral part of Indian culture. For thousands of years, it has been a trusted ingredient in the treatment of various ailments. Yet cannabis is mired in ambiguity when it comes to its application in modern healthcare. Till now, there has been limited debate in India on the medicinal, legal and scientific aspects of using cannabis-derived products as medicine. The goal of this conference is to create an environment of curiosity and discovery within the scientific community and policy makers regarding the wide-ranging industrial and medical benefits of cannabis and help establish an action plan for all stakeholders to engage actively with cannabis for potential future opportunities.”